⌘K

Login Start Free

Home/Filings/4/0001628280-25-053877

4//SEC Filing

NEWHALL CHARLES W III 4

Accession 0001628280-25-053877

CIK 0001356576other

View on SEC.gov Company Profile

Filed

Nov 23, 7:00 PM ET

Accepted

Nov 24, 6:16 PM ET

Size

6.6 KB

Accession

0001628280-25-053877

Insider Transaction Report

Form 4

Period: 2025-11-21

SUPERNUS PHARMACEUTICALS, INC.SUPN

NEWHALL CHARLES W III

Director10% Owner

Transactions

Exercise/Conversion
Common Stock
2025-11-21$12.98/sh+15,000$194,700→ 119,644 total
Exercise/Conversion
Director Stock Option (Right to Buy)
2025-11-21−15,000→ 0 total
Exercise: $12.98From: 2017-03-01Exp: 2026-03-01→ Common Stock (15,000 underlying)

Documents

1 file

4
wk-form4_1764026210.xmlPrimary
FORM 4

Issuer

SUPERNUS PHARMACEUTICALS, INC.

CIK 0001356576

Entity typeother

Related Parties

1

filerCIK 0001005544

Filing Metadata

Form type: 4
Filed: Nov 23, 7:00 PM ET
Accepted: Nov 24, 6:16 PM ET
Size: 6.6 KB

View on SEC.gov